Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.
Charles River Laboratories International Inc. (CRL) saw its stock rise 1.45% to $176.99 on Monday, despite underperforming compared to competitors like Labcorp Holdings Inc. and Alnylam Pharmaceuticals Inc. The S&P 500 Index increased by 0.83%, while CRL remains 22.67% below its 52-week high of $228.88. Trading volume reached 1.0 million, surpassing its 50-day average of 939,356 shares.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments